Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Parkinson

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|December 1, 1988
Interleukin-2 in cancer therapyD R Parkinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Levamisole as adjuvant therapy for melanoma: quo vadis?D R Parkinson
Journal of the National Cancer Institute|September 5, 1990
Interleukin-2: further progress through greater understandingD R Parkinson
Oncology Nursing Forum|November 1, 1989
The role of interleukin-2 in the biotherapy of cancerD R Parkinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The status of plasma therapy as cancer treatmentD R Parkinson
Drug Safety|January 1, 1990
Endogenous substances as drugs. Issues related to the application of cytokines in cancer therapyD R Parkinson
The American Journal of Medicine|December 29, 1995
Present status of biological response modifiers in cancerD R Parkinson
Urology|October 1, 1989
Cytokines in cancer therapyD R Parkinson
Natural Immunity and Cell Growth Regulation|January 1, 1990
Lessons from the clinical trials of interleukin-2D R Parkinson
Natural Immunity and Cell Growth Regulation|January 1, 1990
Interleukin-2, killer cells and cancer therapy: an overviewD R Parkinson, E Lotzová
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|December 1, 1988
Interleukin-2 in cancer therapyD R Parkinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Levamisole as adjuvant therapy for melanoma: quo vadis?D R Parkinson
Journal of the National Cancer Institute|September 5, 1990
Interleukin-2: further progress through greater understandingD R Parkinson
Oncology Nursing Forum|November 1, 1989
The role of interleukin-2 in the biotherapy of cancerD R Parkinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The status of plasma therapy as cancer treatmentD R Parkinson
Drug Safety|January 1, 1990
Endogenous substances as drugs. Issues related to the application of cytokines in cancer therapyD R Parkinson
The American Journal of Medicine|December 29, 1995
Present status of biological response modifiers in cancerD R Parkinson
Urology|October 1, 1989
Cytokines in cancer therapyD R Parkinson
Natural Immunity and Cell Growth Regulation|January 1, 1990
Lessons from the clinical trials of interleukin-2D R Parkinson
Natural Immunity and Cell Growth Regulation|January 1, 1990
Interleukin-2, killer cells and cancer therapy: an overviewD R Parkinson, E Lotzová
Pageof 9